Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Is That A Diagnostic Method Patent Or A Law Of Nature? Supreme Court Hears Arguments

This article was originally published in The Gray Sheet

Executive Summary

A case argued before the Supreme Court Dec. 7 offers the justices an opportunity to place stricter limits on the types of claims that diagnostic makers can latch onto for patent protection. But while the justices had many questions on appropriate standards for patent eligibility, few clear answers surfaced.

Advertisement

Related Content

Supreme Court Overturns Personalized Medicine Patents, Creating Confusion In Diagnostics Realm
No Word Yet On Supreme Court’s Plans For Gene Patent Case
Supreme Court To Hear Prometheus Diagnostics Patent Case
Personalized Med Dx Patent Reaffirmed By Machine-Or-Transformation Test
Supreme Court Gives Some Relief, But Leaves Open Questions For Dx Patents

Topics

Advertisement
UsernamePublicRestriction

Register

MT030801

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel